Commentary
In the name of “gender affirmation,” pre-pubescent children and adolescents diagnosed with gender dysphoria are administered substances that impede natural puberty and prevent the normal development of secondary sex characteristics. These hormones and substances were approved for treating pathologies in adolescence, not for preventing normal maturation. Such “off label” uses of these substances is rank experimentation conducted on children.
